|
Lexington Home Page
|
Help
|
About
|
Browse
Search
2022-11-01-CEC-STM#3-rpt (addendum)
Breadcrumb Navigation:
TownOfLexington-Public
>
WEB PUBLISHED-PUBLIC DOCUMENTS
>
ELECTIONS AND TOWN MEETING ACTION & WARRANTS
>
Town Meeting Minutes and Reports
>
2020-2029
>
2022
>
Reports
>
2022-11-01-CEC-STM#3-rpt (addendum)
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/14/2022 1:37:01 PM
Creation date
11/2/2022 9:21:04 AM
Metadata
Fields
Template:
Archives
Year
2022
Author or Source
Capital Expenditures Committee
Department
Town Clerk
Keywords or Subject
Addendum to the Report of the Capital Expenditure Committee November 1, 2022 Special Town Meeting UPDATE TO CAPITAL EXPENDITURES COMMITTEE REPORT TO STM 2022-3
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
Page 1 of 1
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
UPDATE TO CAPITAL EXPENDITURES COMMITTEE REPORT TO STM 2022-3 <br /> CAPITAL EXPENDITURES COMMITTEE <br /> TOWN OF LEXINGTON <br /> UPDATE TO THE REPORT TO THE <br /> SPECIAL TOWN MEETING (STM) 2022-3 <br /> (Released October 24, 2022) <br /> Released November 1, 2022 <br /> Submitted by: <br /> Charles Lamb, Chair <br /> David G. Kanter, Vice-Chair& Clerk <br /> Sandy Beebee <br /> Michael Boudett <br /> Rodney Cole <br /> Lisah Rhodes <br /> This document provides an update to the Committee's Report with a dollar amount and source that <br /> were identified after the publishing of that Report,but prior to the STM. <br /> On Page 2: Replace the 3rd paragraph beginning "(h)" in its entirety with: <br /> (h) Capital, appropriate $2,375,392 to: Consisting of$1,675,999 from new levy growth per the Capital <br /> Stabilization Fund (CSF) Guideline; and $699,393, a one-time transfer, based on new levy growth under <br /> the Tax Increment Financing (TIF) agreement currently with Takeda Pharmaceuticals (properties at 200, <br /> 300, and 400 Shire Way). <br />
The URL can be used to link to this page
Your browser does not support the video tag.